Andere Sprachen Faron Pharmaceuticals Oy

Aktien

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:06 07.05.2024			% 5 Tage	% 1. Jan.
155 ^GBX	+3.33%		+10.71%	-49.18%

03.05.	Kelso erhöht Beteiligung an NCC; Transense steigt in Projekt ein	AN
30.04.	Faron Pharmaceuticals Ltd. kündigt Ernennung von Dr. Juho Jalkanen zum Direktor an	CI

Kelso raises stake in NCC; Transense joins project	03.05.
Update on financial status	30.04.
Board Change	30.04.
Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director	30.04.
Faron Pharmaceuticals Oy Announces Chief Executive Officer Changes	30.04.
Faron Pharmaceuticals Oy - Insider Information, Appointment of Chief Financial Officer	16.04.
Faron confirms plans under new leadership	16.04.
Faron Confirms Plans for the Coming Months Under New Leadership	16.04.
Faron Pharmaceuticals Oy Confirms Plans for the Coming Months	16.04.
Faron Pharmaceuticals reappoints former finance chief on interim basis	15.04.
Faron Pharmaceuticals Appoints Interim CFO	15.04.
Appointment of Chief Financial Officer	15.04.
Faron Pharmaceuticals Oy Announces Chief Financial Officer Changes	15.04.
Faron Pharmaceuticals promotes COO to CEO as father retires	08.04.
Faron Pharmaceuticals promotes COO to CEO as founder steps back	08.04.
Faron Pharmaceuticals CEO to Retire, COO Named Successor	08.04.
Faron Pharmaceuticals Elects New Chair	08.04.
Approval of Warrant Terms and Conditions	08.04.
Decisions of the Board of Directors	08.04.
Faron Pharmaceuticals Oy Announces Board Changes	08.04.

Keine Ergebnisse zu dieser Suche